While certain British and French experts worry about the consequences for the health of future children who may be born via a new technique of in vitro fertilization (FIV) aimed at preventing the transmission of serious genetic mitochondrial diseases by replacing part of the mitochondrial DNA with healthy DNA obtained from a "third parent", i.e. a woman donor, Shoukhrat Mitalipov, a researcher at the Oregon Health & Science University in the United States, has already carried out tests using human cells. He points out: "Our success with human cells enables us to envisage clinical trials in 2013." His study appeared last autumn in the journal Nature. He adds: "Our patients are just waiting for the green light from the Food and Drug Administration."
United States: “IVF with three parents” tested with humans
Publié le : 10 January 2013